NIFTY  9,360.55  -0.27%
  SENSEX  30,301.60  -0.21%
 CURRENCY  Rs  64.89/$ 72.59/€, 84.18/£
  GOLD  28,710.00  -0.35%
  SILVER  39,830.00  -0.32%
  DAX  12,642.90  -0.13%
  FTSE  7,514.90  0.40%
  CAC  5,341.34  -0.11%
  HANG SENG  25,428.50  0.10%
  NIKKEI  19,743.00  0.66%
  Shanghai Composite  3,064.08  0.03%
  DOW JONES  20,937.90  0.21%
  NASDAQ  6,138.71  0.08%
  S&P 500  2,398.42  0.18%
SOURCES TO COGENCIES : Cabinet Approves Proposal For Abolition Of Foreign Investment Promotion Board SOURCES TO COGENCIES : Cabinet Approves Proposal On 2017-18 Sugarcane Prices SOURCES TO COGENCIES : Need For Cabinet Nod For FDI Over Rs 5000 Cr To Remain TATA INVEST Q4 EARNINGS : PAT Rs 16.1 Cr Vs Rs 22.3 Cr YoY TATA INVEST Q4 EARNINGS : Revenue Rs 35.8 Cr Vs Rs 32.3 Cr YoY TATA INVEST Q4 EARNINGS : To Pay Dividend Of Rs 18/Share PRASUN GAJRI HDFC LIFE : I.T. Stocks May Perform Better On A Short-Term Basis FROM REUTERS : KOC & Tata Group Sign Joint Venture To Tap Into White Goods Consumer Market

Govt Needs To Implement Drug Pricing Policy: IPA

Video:

Play this video

December 31: The government has agreed to review price caps for drugs, approving a petition filed by five pharma majors, including Sun Pharma and Wockhardt, asking it to review the price ceiling. Bloomberg TV India speaks to D.G. Shah, Secretary General, Indian Pharmaceutical Alliance, to know more about the same.